Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.

PubMed ID: 35525297

Author(s): Yaghy A, Lee AY, Keane PA, Keenan TDL, Mendonca LSM, Lee CS, Cairns AM, Carroll J, Chen H, Clark J, Cukras CA, de Sisternes L, Domalpally A, Durbin MK, Goetz KE, Grassmann F, Haines JL, Honda N, Hu ZJ, Mody C, Orozco LD, Owsley C, Poor S, Reisman C, Ribeiro R, Sadda SR, Sivaprasad S, Staurenghi G, Ting DS, Tumminia SJ, Zalunardo L, Waheed NK. Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials. Exp Eye Res. 2022 Jul;220:109092. doi: 10.1016/j.exer.2022.109092. Epub 2022 May 4. No abstract available. PMID 35525297

Journal: Experimental Eye Research, Volume 220, Jul 2022